Zelnorm (also Zelmac) is the brand name for the pharmaceutical product Tegaserod, marketed by Novartis as a remedy for irritable bowel syndrome (IBS) and constipation. Zelnorm was introduced to the U.S. market in 2002, subsequent to Food and Drug Administration (FDA) approval.
In 2007, the FDA asked Novartis to take Zelnorm off the market, based on an analysis of data by the agency. After receiving reports that Zelnorm might be tied to increased risk of stroke or heart attack, the FDA reviewed data from more than 18,000 patients. The study showed that the incidences of cardiovascular problems of people who took Zelnorm was more than 10 times the rate of those who took a placebo.
If you or someone you love has suffered injury after being prescribed Zelnorm, GetLegal has the tools and resources to help you find skilled legal representation to protect your rights. Visit our attorney directory, look for your geographic location and find the best lawyer for your situation.
Defective Drugs & Medical Devices Topics
Happy New Year 2020
Wishing you happy holidays and a wonderful new year. Best wishes from everyone at GetLegal.Read More 23 Dec 2019, Monday
Slip-and-fall Claims on Commercial Property
Your Best Chance of Recovery When You Are Hurt on Business Premises As a general rule, all property…Read More 02 Dec 2019, Monday
Thanksgiving—A Time of Gratitude
Life is about connection… about the power of relationships to help us find and nurture our best se…Read More 27 Nov 2019, Wednesday